Bispecific Antibody targeting IL-1R1 and NLRP3 for Glaucoma

Research output: Patent

Original languageEnglish
Patent numberWO/2020/053446
Filing date2/09/19
Publication statusPublished (in print/issue) - 19 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this